Lyra Therapeutics (LYRA) SEC Filings & 10K Form $0.09 0.00 (-0.65%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.09 +0.00 (+0.87%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Lyra Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/25/20252:41 PMLyra Therapeutics (Subject)Waksal Harlan (Reporting)Form 144Notice of proposed sale of securities pursuant to Rule 144 04/09/20252:44 PMLyra Therapeutics (Subject)Palasis Maria (Reporting)Form 144Notice of proposed sale of securities pursuant to Rule 144 04/04/20257:59 AMLyra Therapeutics (Filer)Form DEF 14A04/04/20258:01 AMLyra Therapeutics (Filer)Form DEFA14A03/25/20253:30 PMLyra Therapeutics (Filer)Form PRE 14A02/14/20255:22 PMCITADEL ADVISORS LLC (Filed by)Lyra Therapeutics (Subject)Form SCHEDULE 13G/A12/16/20248:02 PMLyra Therapeutics (Subject)PERCEPTIVE ADVISORS LLC (Filed by)Form SC 13D/A12/13/20244:06 PMLyra Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/11/20245:39 PMLyra Therapeutics (Issuer)Waksal Harlan (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/11/20245:54 PMLyra Therapeutics (Issuer)Palasis Maria (Reporting)Form 4Statement of changes in beneficial ownership of securities 11/14/20246:48 PMLyra Therapeutics (Subject)Point72 Asset Management, L.P. (Filed by)Form SC 13G/A11/14/20244:48 PMLyra Therapeutics (Subject)Samsara BioCapital, L.P. (Filed by)Form SC 13G/A11/14/20244:49 PMLyra Therapeutics (Subject)Venrock Healthcare Capital Partners II, L.P. (Filed by)Form SC 13G/A11/14/20243:53 PMLyra Therapeutics (Subject)Nantahala Capital Management, LLC (Filed by)Form SCHEDULE 13G/A08/15/20245:31 PMLyra Therapeutics (Subject)PERCEPTIVE ADVISORS LLC (Filed by)Form SC 13D/A07/23/20243:05 PMLyra Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/07/20243:15 PMLyra Therapeutics (Filer)Form 8-K/A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Femasys 10K Form Allurion Technologies 10K Form Nephros 10K Form Retractable Technologies 10K Form OSR 10K Form QT Imaging 10K Form CollPlant Biotechnologies 10K Form NEXGEL 10K Form IRIDEX 10K Form PetVivo 10K Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:LYRA) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LYRA Stock Free LYRA Stock Alerts